腸套疊市場規模、佔有率和成長分析：按類型、治療、診斷、最終用戶和地區分類－2026-2033年產業預測

2024 年全球腸套疊市場價值為 44.4 億美元，預計到 2025 年將成長至 46.8 億美元，到 2033 年將成長至 70.7 億美元，在預測期（2026-2033 年）內複合年成長率為 5.3%。

全球腸套疊市場主要由用於診斷、管理和治療腸套疊的創新產品和服務組成，腸套疊主要發生於嬰幼兒。由於腸套疊可能導致嚴重的併發症，因此迫切需要有效的干預措施，這推動了市場成長。促成這一成長的關鍵因素包括微創復位技術的日益普及，例如超音波引導下空氣灌注和靜水灌腸，這些技術已在很大程度上取代了傳統的手術方法。此外，兒童住院人數的增加和臨床醫生對腸套疊認知的提高也促進了市場的動態，特別體現在東南亞和拉丁美洲對空氣造影灌腸套件的廣泛應用。先進影像技術和遠距遠端醫療的引入正在改善診斷的可及性，尤其是在醫療資源匱乏的地區。與撒哈拉以南非洲地區的合作進一步刺激了市場需求，使製造商處於不斷變化的市場格局的前沿。

全球腸套疊市場成長要素

微創手術日益受到青睞，顯著推動了腸套疊治療領域對創新解決方案的需求。外科醫師越來越關注能夠最大限度減少手術創傷、縮短患者復原時間的治療技術。這一趨勢促進了專用內視鏡器械和成像技術的研發，旨在無需大切口即可檢測和治療腸套疊。隨著臨床醫生對這些療法精準性的認可，醫療機構也更積極地投資於尖端設備，從而帶動了相關產品和服務的市場擴張。積極的臨床療效以及外科醫生對這些新興技術的信心不斷增強，進一步推動了這項投資勢頭。

全球腸套疊市場限制因素

全球腸套疊市場面臨著許多限制因素，其中先進診斷設備的高成本是限制其在資源匱乏的醫療環境中推廣應用的主要障礙。許多醫療機構優先保障基本醫療服務，往往忽略了準確診斷腸套疊所需的昂貴影像技術。預算限制迫使管理者延遲這些技術的應用，導致他們依賴可能不夠準確且會延誤及時治療的傳統方法。因此，在經濟困難地區，製造商的銷售額較低，造成市場滲透率不平衡。這種經濟障礙也阻礙了研發投入，延緩了技術進步。

全球腸套疊市場趨勢

在全球腸套疊市場，創新的生物可吸收器材應用日益普及，其安全性和有效性正獲得臨床醫師的廣泛認可。製造商正加速研發治療後可自然溶解的生物可吸收支架和導管，導致對此類解決方案的需求激增，尤其是在小兒科和微創手術領域。這一趨勢的驅動力在於越來越多的證據支持其有效性、降低併發症率以及改善患者復原體驗。此外，醫療設備開發商與學術研究人員之間的策略合作正在提升可吸收技術的信譽度和應用範圍，鞏固其在腸套疊治療領域變革性作用的地位。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球腸套疊市場規模：按類型分類

• 特發性腸套疊
• 續發性腸套疊

全球腸套疊市場規模：依治療方法分類

• 灌腸減壓
  • 空氣灌腸
  • 鋇灌腸
  • 水溶性造影劑灌腸劑
• 外科手術
  • 腹腔鏡手術
  • 開放性手術
• 其他治療方法

全球腸套疊市場規模：依診斷分類

• 超音波檢查
• X光
• 電腦斷層掃描
• 鋇灌腸檢查

全球腸套疊市場規模：依最終用戶分類

• 醫院
• 專科診所
• 診斷中心

全球腸套疊市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Pfizer Inc.
• Merck & Co. Inc.
• Bayer AG
• Novartis AG
• Bristol-Myers Squibb Company
• Abbott Laboratories
• Sanofi SA
• GlaxoSmithKline PLC
• Stryker Corporation
• Boston Scientific Corporation
• Olympus Corporation
• GE HealthCare Technologies Inc.
• Steris PLC
• Cook Medical LLC
• CONMED Corporation
• Karl Storz SE & Co. KG
• Fujifilm Healthcare Solutions
• Richard Wolf GmbH
• Janssen Pharmaceuticals Inc.
• EndoChoice Holdings Inc.

結論與建議

Global Intussusception Market size was valued at USD 4.44 Billion in 2024 and is poised to grow from USD 4.68 Billion in 2025 to USD 7.07 Billion by 2033, growing at a CAGR of 5.3% during the forecast period (2026-2033).

The global intussusception market is centered on innovative products and services for diagnosing, managing, and treating intussusception, a condition predominantly affecting infants. The urgency for effective interventions stems from the potential for serious complications, driving market growth. Key factors propelling this expansion include the increasing use of minimally invasive reduction techniques such as ultrasound-guided pneumatic and hydrostatic enemas, which have largely replaced traditional surgical methods. Additionally, rising pediatric hospital admissions and growing awareness among clinicians contribute to market dynamics, notably seen through the adoption of air-contrast enema kits in regions like Southeast Asia and Latin America. The incorporation of advanced imaging technology and telemedicine enhances diagnostic access, particularly in underserved areas, while partnerships in sub-Saharan Africa further boost demand, positioning manufacturers at the forefront of the evolving market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intussusception market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intussusception Market Segments Analysis

Global intussusception market is segmented by type, treatment, diagnosis, end user and region. Based on type, the market is segmented into Idiopathic Intussusception and Secondary Intussusception. Based on treatment, the market is segmented into Enema Reduction, Surgery and Other Treatments. Based on diagnosis, the market is segmented into Ultrasound, X-Ray, CT Scan and Barium Enema. Based on end user, the market is segmented into Hospitals, Specialty Clinics and Diagnostic Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intussusception Market

The growing preference for minimally invasive procedures is significantly boosting the demand for innovative solutions in intussusception management. Surgeons are increasingly drawn to techniques that minimize operational trauma and enhance patient recovery times. This trend has sparked advancements in the development of specialized endoscopic instruments and imaging technologies designed for the detection and treatment of intussusception without the necessity of large incisions. As clinicians appreciate the precision afforded by these interventions, healthcare facilities are more likely to invest in cutting-edge equipment, leading to an expansion of the market for associated products and services. This investment momentum is further supported by favorable clinical outcomes and heightened surgeon confidence in these emerging technologies.

Restraints in the Global Intussusception Market

The global intussusception market faces significant limitations due to the high costs associated with advanced diagnostic equipment, which hinders its adoption in low-resource healthcare environments. Many healthcare facilities prioritize essential services, often overlooking the expensive imaging technologies necessary for accurate identification of intussusception. Budget constraints lead administrators to postpone the acquisition of such technologies, resulting in a reliance on traditional methods that lack precision and can impede timely treatment. Consequently, manufacturers experience lower sales in regions where financial challenges are severe, leading to uneven market penetration. This financial hurdle also stifles investments in research and development, thereby slowing technological advancements.

Market Trends of the Global Intussusception Market

The Global Intussusception market is witnessing a significant trend towards the adoption of innovative bioabsorbable devices, which are increasingly favored by clinicians for their safety and efficacy. With manufacturers accelerating the development of bioabsorbable stents and catheters that dissolve naturally post-treatment, the demand for these solutions is surging, particularly in pediatric and minimally invasive procedures. This trend is fueled by a growing body of evidence supporting their effectiveness, reduced complication rates, and enhanced recovery experiences for patients. Additionally, strategic collaborations between device developers and academic researchers are enhancing the credibility and integration of absorbable technologies, cementing their role as a transformative force in the treatment of intussusception.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Intussusception Market Size by Type & CAGR (2026-2033)

• Market Overview
• Idiopathic Intussusception
• Secondary Intussusception

Global Intussusception Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• Enema Reduction
  • Air Enema
  • Barium Enema
  • Water-Soluble Contrast Enema
• Surgery
  • Laparoscopic Surgery
  • Open Surgery
• Other Treatments

Global Intussusception Market Size by Diagnosis & CAGR (2026-2033)

• Market Overview
• Ultrasound
• X-Ray
• CT Scan
• Barium Enema

Global Intussusception Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Diagnostic Centers

Global Intussusception Market Size & CAGR (2026-2033)

• North America (Type, Treatment, Diagnosis, End User)
  • US
  • Canada
• Europe (Type, Treatment, Diagnosis, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Treatment, Diagnosis, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Treatment, Diagnosis, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Treatment, Diagnosis, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Steris PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CONMED Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Karl Storz SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Healthcare Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Richard Wolf GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janssen Pharmaceuticals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EndoChoice Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations